机构：[1]Hospital for Skin Diseases (Institute of Dermatology), Chinese Academy of Medical Sciences and Peking Union Medical College and National Center for STD Control, Chinese Centers for Disease Control and Prevention, Nanjing, Jiangsu 210042, China[2]Department of Dermatology, Affiliated Wuxi No. 2 People’s Hospital of Nanjing Medical University, Wuxi, Jiangsu 214002, China[3]Department of Dermatology, General Hospital of Tianjing Medical University, Tianjing 300052, China[4]Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China[5]Department of Neurology, Ditan Hospital of Capital Medical University, Beijing 100050, China[6]Department of Dermatology, Shanghai Hospital for Skin Disease and STD of Tongji University, Shanghai 200050, China[7]Department of Dermatology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China内科科室皮肤科昆明医科大学附属第一医院[8]Department of Dermatology, The 5th People’s Hospital of Suzhou, Suzhou, Jiangsu 215007 China[9]Department of Dermatology, The First Affiliated Hospital of General Hospital of PLA, Beijing 100048, China[10]Department of Dermatology, The Skin Disease Hospital of Southern Medical University, Guangzhou, Guangdong 510091 China[11]Department of Dermatology, Sir Run Run Shaw Hospital of Zhejiang University, Hangzhou, Zhejiang 310020, China.
Gonorrhea is one of the main sexually transmitted diseases in China. It mainly affects the genitourinary tract, and its
clinical manifestations vary from asymptomatic to complicated types. The diagnosis of gonorrhea should be based on
the patient’s epidemiological history, clinical manifestations, and laboratory examination results. Treatment should be
prompt and standardized and should involve the recommended treatment regimens. Patients should be appropriately
followed up after treatment. The antimicrobial resistance of gonococcal isolates has become a severe problem of clinical
concern. In order to provide technical guidance of the diagnosis and treatment of gonorrhea for health care workers, the
authors developed the guidelines based on the version of 2014, which will be of important in the standardizing medical
care of gonorrhea, and further facilitating control and prevention of the disease.
基金：
This study was supported by the Union Innovation Project
of the Chinese Academy of Medical Sciences (No. 2016-
I2M-3021) and the National Natural Science Foundation
of China (No. 81772209 and No. 81601804).
语种：
外文
第一作者：
第一作者机构：[1]Hospital for Skin Diseases (Institute of Dermatology), Chinese Academy of Medical Sciences and Peking Union Medical College and National Center for STD Control, Chinese Centers for Disease Control and Prevention, Nanjing, Jiangsu 210042, China
通讯机构：[*1]Hospital for Skin Diseases (Institute of Dermatology), Chinese Academy of Medical Sciences and Peking Union Medical College and National Center for STD Control, Chinese Centers for Disease Control and Prevention, Nanjing, Jiangsu 210042, China.
推荐引用方式(GB/T 7714)：
Qian-Qiu Wang,Rui-Li Zhang,Quan-Zhong Liu,et al.National Guidelines on Diagnosis and Treatment of Gonorrhea in China (2020)[J].Inertnational Journal of dermatology And Venereology.2020,(3):doi:10.1097/JD9.0000000000000072.
APA：
Qian-Qiu Wang,Rui-Li Zhang,Quan-Zhong Liu,Jin-Hua Xu,Xiao-Hong Su...&Committee of STD, Chinese Dermatologist Association.(2020).National Guidelines on Diagnosis and Treatment of Gonorrhea in China (2020).Inertnational Journal of dermatology And Venereology,,(3)
MLA：
Qian-Qiu Wang,et al."National Guidelines on Diagnosis and Treatment of Gonorrhea in China (2020)".Inertnational Journal of dermatology And Venereology ..3(2020)
